Clinical trial

Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation…

NCT00177424 · University of Pittsburgh, Other · Terminated

Key facts

NCT number NCT00177424
Title Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes
Official title Intervention to Prevent Post-Stroke Major Depression.
Lead sponsor University of Pittsburgh, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Cerebrovascular Accident, Depression
Intervention type Drug
Interventions sertraline, Placebo
Enrollment 154
Start date Jul 1, 2004
Primary completion Oct 1, 2007
Completion Oct 1, 2007
First posted Sep 15, 2005
Last update posted Jun 27, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies